Cargando…

Latest development in the synthesis of ursodeoxycholic acid (UDCA): a critical review

Ursodeoxycholic acid (UDCA) is a pharmaceutical ingredient widely used in clinics. As bile acid it solubilizes cholesterol gallstones and improves the liver function in case of cholestatic diseases. UDCA can be obtained from cholic acid (CA), which is the most abundant and least expensive bile acid...

Descripción completa

Detalles Bibliográficos
Autores principales: Tonin, Fabio, Arends, Isabel W C E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Beilstein-Institut 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5827811/
https://www.ncbi.nlm.nih.gov/pubmed/29520309
http://dx.doi.org/10.3762/bjoc.14.33
_version_ 1783302540624920576
author Tonin, Fabio
Arends, Isabel W C E
author_facet Tonin, Fabio
Arends, Isabel W C E
author_sort Tonin, Fabio
collection PubMed
description Ursodeoxycholic acid (UDCA) is a pharmaceutical ingredient widely used in clinics. As bile acid it solubilizes cholesterol gallstones and improves the liver function in case of cholestatic diseases. UDCA can be obtained from cholic acid (CA), which is the most abundant and least expensive bile acid available. The now available chemical routes for the obtainment of UDCA yield about 30% of final product. For these syntheses several protection and deprotection steps requiring toxic and dangerous reagents have to be performed, leading to the production of a series of waste products. In many cases the cholic acid itself first needs to be prepared from its taurinated and glycilated derivatives in the bile, thus adding to the complexity and multitude of steps involved of the synthetic process. For these reasons, several studies have been performed towards the development of microbial transformations or chemoenzymatic procedures for the synthesis of UDCA starting from CA or chenodeoxycholic acid (CDCA). This promising approach led several research groups to focus their attention on the development of biotransformations with non-pathogenic, easy-to-manage microorganisms, and their enzymes. In particular, the enzymatic reactions involved are selective hydrolysis, epimerization of the hydroxy functions (by oxidation and subsequent reduction) and the specific hydroxylation and dehydroxylation of suitable positions in the steroid rings. In this minireview, we critically analyze the state of the art of the production of UDCA by several chemical, chemoenzymatic and enzymatic routes reported, highlighting the bottlenecks of each production step. Particular attention is placed on the precursors availability as well as the substrate loading in the process. Potential new routes and recent developments are discussed, in particular on the employment of flow-reactors. The latter technology allows to develop processes with shorter reaction times and lower costs for the chemical and enzymatic reactions involved.
format Online
Article
Text
id pubmed-5827811
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Beilstein-Institut
record_format MEDLINE/PubMed
spelling pubmed-58278112018-03-08 Latest development in the synthesis of ursodeoxycholic acid (UDCA): a critical review Tonin, Fabio Arends, Isabel W C E Beilstein J Org Chem Review Ursodeoxycholic acid (UDCA) is a pharmaceutical ingredient widely used in clinics. As bile acid it solubilizes cholesterol gallstones and improves the liver function in case of cholestatic diseases. UDCA can be obtained from cholic acid (CA), which is the most abundant and least expensive bile acid available. The now available chemical routes for the obtainment of UDCA yield about 30% of final product. For these syntheses several protection and deprotection steps requiring toxic and dangerous reagents have to be performed, leading to the production of a series of waste products. In many cases the cholic acid itself first needs to be prepared from its taurinated and glycilated derivatives in the bile, thus adding to the complexity and multitude of steps involved of the synthetic process. For these reasons, several studies have been performed towards the development of microbial transformations or chemoenzymatic procedures for the synthesis of UDCA starting from CA or chenodeoxycholic acid (CDCA). This promising approach led several research groups to focus their attention on the development of biotransformations with non-pathogenic, easy-to-manage microorganisms, and their enzymes. In particular, the enzymatic reactions involved are selective hydrolysis, epimerization of the hydroxy functions (by oxidation and subsequent reduction) and the specific hydroxylation and dehydroxylation of suitable positions in the steroid rings. In this minireview, we critically analyze the state of the art of the production of UDCA by several chemical, chemoenzymatic and enzymatic routes reported, highlighting the bottlenecks of each production step. Particular attention is placed on the precursors availability as well as the substrate loading in the process. Potential new routes and recent developments are discussed, in particular on the employment of flow-reactors. The latter technology allows to develop processes with shorter reaction times and lower costs for the chemical and enzymatic reactions involved. Beilstein-Institut 2018-02-20 /pmc/articles/PMC5827811/ /pubmed/29520309 http://dx.doi.org/10.3762/bjoc.14.33 Text en Copyright © 2018, Tonin and Arends https://creativecommons.org/licenses/by/4.0https://www.beilstein-journals.org/bjoc/termsThis is an Open Access article under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The license is subject to the Beilstein Journal of Organic Chemistry terms and conditions: (https://www.beilstein-journals.org/bjoc/terms)
spellingShingle Review
Tonin, Fabio
Arends, Isabel W C E
Latest development in the synthesis of ursodeoxycholic acid (UDCA): a critical review
title Latest development in the synthesis of ursodeoxycholic acid (UDCA): a critical review
title_full Latest development in the synthesis of ursodeoxycholic acid (UDCA): a critical review
title_fullStr Latest development in the synthesis of ursodeoxycholic acid (UDCA): a critical review
title_full_unstemmed Latest development in the synthesis of ursodeoxycholic acid (UDCA): a critical review
title_short Latest development in the synthesis of ursodeoxycholic acid (UDCA): a critical review
title_sort latest development in the synthesis of ursodeoxycholic acid (udca): a critical review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5827811/
https://www.ncbi.nlm.nih.gov/pubmed/29520309
http://dx.doi.org/10.3762/bjoc.14.33
work_keys_str_mv AT toninfabio latestdevelopmentinthesynthesisofursodeoxycholicacidudcaacriticalreview
AT arendsisabelwce latestdevelopmentinthesynthesisofursodeoxycholicacidudcaacriticalreview